Overview

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety of GCS therapy for phase I and efficacy of GCS therapy for phase II.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Kansai Hepatobiliary Oncology Group
Treatments:
Cisplatin
Gemcitabine